COP regimen: Difference between revisions
No edit summary |
|||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of | {{PAGENAME}} refers to a regimen consisting of [[cyclophosphamide]], [[vincristine]], and [[prednisone]] used to treat [[lymphoma|Malignant lymphoma]]. | ||
==Regimen== | ==Regimen== | ||
{{chemo| | {{chemo|C|Cyclophosphamide}} | ||
{{chemo| | {{chemo|V|Vincristine}} | ||
{{chemo| | {{chemo|P|Prednisone}} | ||
==Indications== | ==Indications== |
Revision as of 13:03, 12 March 2015
WikiDoc Resources for COP regimen |
Articles |
---|
Most recent articles on COP regimen Most cited articles on COP regimen |
Media |
Powerpoint slides on COP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on COP regimen at Clinical Trials.gov Clinical Trials on COP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on COP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on COP regimen Discussion groups on COP regimen Patient Handouts on COP regimen Directions to Hospitals Treating COP regimen Risk calculators and risk factors for COP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for COP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
COP regimen refers to a regimen consisting of cyclophosphamide, vincristine, and prednisone used to treat Malignant lymphoma.
Regimen
CCyclophosphamide
VVincristine
PPrednisone
Indications
References
- ↑ Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL; et al. (1971). "Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma". Cancer. 28 (2): 306–17. PMID 4935774.